LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Yearbook of Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.YEND.2012.05.033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.

  2012cited by this paper
• Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.

  2010cited by this paper
• Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

  2009cited by this paper
• Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden

  2008cited by this paper
• Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

  2007cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• High-density lipoprotein cholesterol in the cardiovascular equation: does the "good" still count?

  2005cited by this paper
• Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

  2000cited by this paper

• HDL proteome: from its characterization to quantitative measurements in particle subspecies and functional associations

  2025cites this paper
• The Association of the Cholesterol Efflux Capacity with theParaoxonase 1 Q192R Genotype and the Paraoxonase Activity

  2024cites this paper
• New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease

  2024cites this paper
• Clinical incidence and relevance of incomplete endothelialization in atrial fibrillation patients with Left Atrial Appendage Closure

  2024cites this paper
• The potential of platelet to high-density lipoprotein cholesterol ratio (PHR) as a novel biomarker for heart failure

  2024cites this paper
• Abnormal Lipid Profile Level in Neonates and Possible Development of Atherosclerosis in Adulthood: Mini Review

  2024cites this paper
• Frequencies of variants in genes associated with dyslipidemias identified in Costa Rican genomes

  2023influential citation
• Leveraging family data to design Mendelian Randomization that is provably robust to population stratification

  2023cites this paper
• Very low HDL levels: clinical assessment and management

  2023cites this paper
• Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction

  2023cites this paper
• Study the level of some serum lipid profile parameters in patients with an ischemic heart disease

  2023cites this paper
• High-density lipoproteins and non-alcoholic fatty liver disease

  2023cites this paper
• Paradoxical mortality differential of HDL cholesterol

  2023cites this paper
• Association of Baseline Metabolomic Profiles With Incident Stroke and Dementia and With Imaging Markers of Cerebral Small Vessel Disease

  2023cites this paper
• Longitudinal effects of lipid indices on incident cardiovascular diseases adjusting for time-varying confounding using marginal structural models: 25 years follow-up of two US cohort studies

  2022cites this paper
• High-density lipoprotein revisited: biological functions and clinical relevance

  2022cites this paper
• Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B

  2022cites this paper
• Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019–2020

  2022cites this paper
• Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia

  2022cites this paper
• High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study

  2022cites this paper
• The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis

  2022cites this paper
• Metabolic associations with stroke, dementia, and imaging markers of cerebral small vessel disease: a comprehensive metabolomics study

  2022cites this paper
• Urinary Albumin-Creatinine Ratio (UACR), Even within Normal Range, and Risk of Hypertension (HTN), Type 2 Diabetes Mellitus (T2DM), HTN with T2DM, Dyslipidemia and Cardiovascular Diseases in the Chinese Population: A Report from REACTION Study

  2022cites this paper
• A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency

  2022cites this paper
• Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

  2022cites this paper
• HDL Is Not Dead Yet

  2022cites this paper
• Functional diversity of high-density lipoproteins: finding the golden mean

  2021cites this paper
• Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population‐Based Study

  2021cites this paper
• HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role

  2021cites this paper
• HDL and type 2 diabetes: the chicken or the egg?

  2021cites this paper
• Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies

  2021cites this paper
• LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred

  2021cites this paper
• Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease

  2021cites this paper
• Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases

  2021cites this paper
• Genetically-engineered hamster models: applications and perspective in dyslipidemia and atherosclerosis-related cardiovascular disease

  2021cites this paper
• Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile

  2020cites this paper
• In-depth Mendelian randomization analysis of causal factors for coronary artery disease

  2020cites this paper
• Effect of Chinese herbal medicine on serum lipids in postmenopausal women with mild dyslipidemia: a randomized, placebo-controlled clinical trial.

  2020cites this paper
• The Rise and Fall “ing” of the HDL Hypothesis

  2020cites this paper
• LCAT Deficiency in Amerindian Populations: A Systematic Review With the Clinical and Genetic Description of Mexican Kindred

  2020cites this paper
• REC: CardioClinics

  2020cites this paper
• Low HDL (High-Density Lipoprotein) Cholesterol and High White Blood Cell Counts: A Mendelian Randomization Study.

  2020cites this paper
• High-Density Lipoprotein-Targeted Therapies for Heart Failure

  2020cites this paper
• HDL Proteome and Alzheimer’s Disease: Evidence of a Link

  2020cites this paper
• Ethanol-mediated upregulation of APOA1 gene expression in HepG2 cells is independent of de novo lipid biosynthesis

  2020cites this paper
• Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study

  2019cites this paper
• Genetic studies of cardiometabolic traits

  2019influential citation
• Precision Medicine and Cardiovascular Health: Insights from Mendelian Randomization Analyses

  2019cites this paper
• Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome

  2019cites this paper
• Oxidation products of arachidonic acid within lipoproteins and their effects on macrophage migration

  2019influential citation
• Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits.

  2019cites this paper
• High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery

  2019cites this paper
• HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.

  2019cites this paper
• Genetic and secondary causes of severe HDL deficiency and cardiovascular disease1

  2018cites this paper
• Modified lipoproteins as biomarkers of atherosclerosis.

  2018cites this paper
• Is It Time for New Thinking About High-Density Lipoprotein?

  2018cites this paper
• Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes.

  2018cites this paper
• Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides

  2018cites this paper
• HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

  2018cites this paper
• Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within

  2018cites this paper
• Life course socioeconomic position, alcohol drinking patterns in midlife, and cardiovascular mortality: Analysis of Norwegian population-based health surveys

  2018cites this paper
• The role of interleukin-32 in the increased cardiovascular risk associated with chronic inflammatory diseases

  2018cites this paper
• Dyslipidemia in the Young: From Genotype to Treatment

  2018cites this paper
• Impact d'interventions non pharmacologiques sur les biomarqueurs émergents du risque cardiovasculaire : fonctionnalité des HDL et PCSK9

  2018cites this paper
• Plasma HDL cholesterol and risk of myocardial infarction

  2018cites this paper
• Genetic determinants of the human plasma proteome and their application in biology and disease

  2017cites this paper
• Interaction of lecithin-cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I derived peptides: implications for the cofactor mechanism of apolipoprotein A-I

  2017influential citation
• Dietary fats and cardiovascular disease

  2017cites this paper
• Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level

  2017cites this paper
• HDL and the menopause.

  2017cites this paper
• Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31

  2017cites this paper
• Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome.

  2017cites this paper
• Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions

  2017cites this paper
• Genetics of Lipid and Lipoprotein Disorders and Traits

  2016cites this paper
• Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.

  2016cites this paper
• Insight into rheumatological cause and effect through the use of Mendelian randomization

  2016cites this paper
• Cholesterol as a Risk Factor for Subarachnoid Hemorrhage: A Systematic Review

  2016cites this paper
• Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.

  2016cites this paper
• Obtaining causal estimates of therapeutic effects in observational studies : the usefulness and validity of physician’s preference as an instrumental variable

  2016cites this paper
• Cerebrovascular integrity maintenance and inflammation in atherosclerosis animal models

  2016cites this paper
• Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.

  2016cites this paper
• Mining genomic variants and causal pathways linking HDL and triglycerides to coronary disease

  2016cites this paper
• High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis

  2016cites this paper
• A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity.

  2016cites this paper
• Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

  2016cites this paper
• „Residuales Risiko“: Wie wichtig sind High-Density-Lipoproteine und Triglyzeride?

  2016cites this paper
• Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options

  2016cites this paper
• Hypertriglyceridemia, remnant cholesterol and cardiovascular risk: what genes can say

  2016cites this paper
• Rare Genetic Variants and High-Density Lipoprotein: Marching to a Different Drum.

  2016cites this paper
• Institutet , Stockholm , Sweden STUDIES ON CHOLESTEROL AND BILE ACID METABOLISM IN RELATION TO PLASMA LIPOPROTEINS IN HUMANS

  2016cites this paper
• Metabolomics in epidemiology: from metabolite concentrations to integrative reaction networks

  2016cites this paper
• Role of LCAT in Atherosclerosis.

  2016cites this paper
• Mendelian randomization studies of biomarkers and type 2 diabetes

  2015cites this paper
• Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease

  2015cites this paper
• Mendelian randomization studies: a review of the approaches used and the quality of reporting.

  2015cites this paper
• A review on lecithin:cholesterol acyltransferase deficiency.

  2015cites this paper
• Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]

  2015cites this paper
• HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study

  2015cites this paper
• Investigation of total HDL and HDL subclass kinetics using stable isotope techniques in healthy subjects

  2015cites this paper
• Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials

  2015cites this paper